$8 Million NIH Grant Will Fund Multicenter Clinical Trial of Stroke Intervention Drug

Award to Cedars-Sinai Stroke Intervention Researchers Supports Collaborative Study Involving National Institute of Neurological Disorders and Stroke

Los Angeles - April 22, 2014 – Cedars-Sinai stroke intervention researchers have been informed that the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, will award an $8 million grant to fund a multicenter Phase II clinical trial of an experimental drug for stroke.

The drug, 3K3A-APC, will be used in combination with recombinant tissue plasminogen activator, or rtPA – the "clot-busting" drug currently approved...

April 22, 2014  |  Read Full Story

News Releases

Cedars-Sinai Nurses Now Screening All Hospitalized Adult Patients for Depression

April 21, 2014  |  Read Full Story

Cedars-Sinai Experts in Lou Gehrig's Disease Present Conference for Patients and Families

April 11, 2014  |  Read Full Story

Research Studies Highlight Advantages and Potential of Computer-Guided Spinal Surgery

April 3, 2014  |  Read Full Story

$2.5 Million Defense Department Grant Funds Gene Therapy Study for Lou Gehrig's Disease

April 1, 2014  |  Read Full Story

Two Cedars-Sinai Heart Institute Physicians Honored by American College of Cardiology

March 27, 2014  |  Read Full Story

Cedars-Sinai Department of Pathology and Laboratory Medicine Named 2014 Lab of the Year

March 27, 2014  |  Read Full Story

Cedars-Sinai Designing 'Operating Room of the Future' to Streamline, Improve Trauma Care

March 25, 2014  |  Read Full Story